Skip to content

Comparison remifentanil and dexmedtomidine effects in post spinal fusion surgery

Comparison the effects of intravenous remifentanil and dexmedtomidine in post spinal fusion surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012081410336N3
Enrollment
50
Registered
2012-12-28
Start date
2012-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal fusion surgeries.

Interventions

Intervention 1: Prescribe two different drugs and monitor their hemodynamic effects 1- first group will receive remifentanil infusion as an anesthesia maintenance with 0.2micro/Kg/min dosage and mo
Treatment - Drugs
Prescribe two different drugs and monitor their hemodynamic effects 1- first group will receive remifentanil infusion as an anesthesia maintenance with 0.2micro/Kg/min dosage and monitor for hemod
Second group will receive dexmedtomidine infusion during surgery as anesthesia maintenance regimen with 1 micro/Kg/hr dosage and will be monitored.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-Patients between 15-65 years 2-With American Society of anethesiologist grade I& II 3-Candidated for posterior spinal fusion surgery maximally at 3 levels 4-sign informed consent Exclusion criteria: Having heart, lung, renal and hepatic diseases, coagulopathy No sign the informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: each hour. Method of measurement: mmHg-automatic device.

Secondary

MeasureTime frame
Heart rate. Timepoint: each hour. Method of measurement: beat/min-automatic device.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactpoupak Rahimzadeh

Tehran university of medical sciences

p-rahimzadeh@tums.ac.ir+98 21 6650 9059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026